Table.1.
Patient Characteristics for all 2011 U.S. Medicare Beneficiaries diagnosed with Adhesive Capsulitis
| All Adhesive Capsulitis Cases (N = 92,437) |
|
|---|---|
| N (%) | |
| Male | 33,012 (35.7) |
| Race | |
| Asian | 2,628 (2.8) |
| Black | 6,199 (6.7) |
| Hispanic | 1,620 (1.8) |
| Other | 2,186 (2.4) |
| White | 79,804 (86.3) |
| Dual eligible for Medicaida | 10,999 (11.9) |
| Mean Age (Standard Deviation) | 75.7 (7.0) |
| Age Group | |
| 66–69 | 24,026 (26.0) |
| 70–75 | 29,143 (31.5) |
| 76–79 | 14,380 (15.6) |
| 80–85 | 15,628 (16.9) |
| 86 + | 9,260 (10.0) |
| Region | |
| Midwest | 18,758 (20.3) |
| Northeast | 19,310 (20.9) |
| South | 37,440 (40.5) |
| West | 16,334 (17.7) |
| Charlson Comorbidity Index (CCI) | |
| 0 | 24,775 (26.8) |
| 1 | 20,391 (22.1) |
| 2 | 14,683 (15.9) |
| 3 | 11,426 (12.4) |
| 4 + | 21,162 (22.9) |
| Frailty Risk Index (FRI) | |
| 0 | 34,721 (37.6) |
| 1 | 30,776 (33.3) |
| 2 | 13,593 (14.7) |
| 3 + | 13,347 (14.4) |
| Mean Previous Year Medicare Spending (SD)b | $14,176 (23,287) |
| Comorbidities | |
| Diabetes, Type 1 | 3,220 (3.5) |
| Diabetes, Type 2 | 28,611 (31.0) |
| Hyperlipidemia | 41,106 (44.5) |
| Hypertension | 53,979 (58.4) |
| Thyroid Disorder | 16,364 (17.7) |
| Rheumatoid arthritis | 3,883 (4.2) |
| Gout | 2,744 (3.0) |
| Parkinson’s Disease | 1,299 (1.4) |
a Beneficiary was fully dual-eligible for Medicare and Medicaid during the month the index shoulder visit occurred
b Total Part A and B payments made by Medicare for the beneficiary over the period of 365-days prior to their index shoulder date